Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126246111 | 12624611 | 1 | I | 20160728 | 20160805 | 20160805 | EXP | AU-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-063459 | BRISTOL MYERS SQUIBB | 34.00 | YR | M | Y | 0.00000 | 20160805 | CN | AU | AU |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126246111 | 12624611 | 1 | PS | ABILIFY | ARIPIPRAZOLE | 1 | Oral | 30 MG, QD | Y | 21436 | 30 | MG | TABLET | QD | |||||
| 126246111 | 12624611 | 2 | SS | ABILIFY | ARIPIPRAZOLE | 1 | Oral | 40 MG, QD | Y | 21436 | 40 | MG | TABLET | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126246111 | 12624611 | 1 | Schizophrenia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126246111 | 12624611 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126246111 | 12624611 | Dyskinesia | |
| 126246111 | 12624611 | Prescribed overdose | |
| 126246111 | 12624611 | Psychotic disorder |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |